Akorn Inc's

Name: Akorn Inc Comparisons to its Competitors and Market Share - CSIMarket
Creator: CSIMarket.com
License: https://csimarket.com/help/terms-of-use/

Competitiveness

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

AKRXQ Sales vs. its Competitors Q2 2020

Comparing the current results to its competitors, Akorn Inc reported Revenue decrease in the 2 quarter 2020 year on year by -32.43 %, faster than the overall decrease of Akorn Inc's competitors by -19.83 %, recorded in the same quarter.

• List of AKRXQ Competitors

Select the Relationship:

Competition ▼

Select the Category:

Comparison ▼

Competition ▼

Basic Report▼

Revenue Growth Comparisons

Net Income Comparison

Akorn Inc, faster than the decline experienced by the competitors recorded a net loss, as well as most of its competitors.

<< AKRXQ Stock Performance Comparisons

<< See the full list of AKRXQ competitors

Overall company Market Share Q2 2020

Overall company, revenue fell by -32.43 % and company lost market share, to approximately 58.37 %. << More on AKRXQ Market Share.

*Market share is calculated based on total revenue.

AKRXQ's Stock Performance relative to its Competitors

Publicly Traded Peers of Akorn Inc

Amphastar Pharmaceuticals Inc
Share Performance

-26.87%

One Year

Amphastar Pharmaceuticals Inc

Profile

Amphastar Pharmaceuticals Inc's business model revolves around developing, manufacturing, and marketing specialty pharmaceutical products. The company focuses on niche markets and primarily produces finished dosage form and active pharmaceutical ingredients (APIs) for injectable, inhalation, and intranasal delivery systems. Amphastar aims to provide innovative and cost-effective solutions for complex therapeutic needs, while maintaining regulatory compliance and ensuring the highest standard of quality.

More about Amphastar Pharmaceuticals Inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 1,046.699 mill.	$ 720.530 mill.	$ 79.229 mill.

Hyperion Defi inc
Share Performance

-0.58%

This Quarter

Hyperion Defi inc

Profile

Hyperion DeFi manages a treasury of Hyperliquid's token and develops ophthalmic technology.

More about Hyperion Defi inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 43.387 mill.	$ 1.043 mill.	$ -37.780 mill.

Sources: Akorn Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Saturday, August 29, 2026 5:24 PM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Akorn Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.